Received Jun 17, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z013052 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | H3729 | IM / LA |
We are unaware of any side effects to patient. However, provider had ordered for patient to get Prevnar 20 and TDAP. MA administered Capvaxive 21 in error. Per review of patient, was eligible for either vaccine.
Mild persistent asthma (HCC) Major depressive disorder, single episode, moderate (HCC) Allergic rhinitis GAD (generalized anxiety disorder) Hyperlipidemia Post traumatic stress disorder History of nephrectomy Encounter for screening for malignant neoplasm of cervix Cyst of left ovary
albuterol HFA 90 mcg/actuation inhaler 2 Puff, inhalation, Every 4 hours PRN ALPRAZolam (XANAX) 0.5 mg tablet 0.5 mg, oral, Daily PRN escitalopram (LEXAPRO) 10 mg tablet 15 mg, oral, Daily estradiol (CLIMARA) 0.02
Erythromycin-Nausea and Vomiting Penicillin G-Rash Phenobarbital-unknown